Market Overview:
The global sleep apnea diagnostics and therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of sleep apnea, rising awareness about sleep apnea and its treatment options, and technological advancements in the field of sleep apnea diagnostics. The global sleep apnea diagnostics and therapeutics market is segmented on the basis of type into polysomnography (PSG) devices, actigraphy systems, respiratory polygraphs, pulse oximeters, and others. On the basis of application, the market is segmented into drug manufacturers, hospitals and clinics, private and government research institutes academic institutes).
Product Definition:
Sleep apnea is a sleep disorder characterized by pauses in breathing or periods of shallow breathing during sleep. Each pause in breathing, called an apnea, can last from a few seconds to minutes, and may occur 5 to 30 times or more per hour. Most people with sleep apnea don't know they have it because it only occurs during sleep.
Polysomnography (PSG) Devices:
PSG devices are used to diagnose and treat sleep disorders. They record the electrical activity of the brain and other body functions during sleep. Polysomnography is an advanced test that includes respiratory events, heart rate, blood oxygen level, snoring & breathing pattern along with temperature sensors that are connected to a monitor which displays all data on screen in a split second.
Actigraphy Systems:
Actigraphy is a system used to measure and record the movements of the patient during sleep. It is an instrument that can be worn by patients or attached to the bed as and when required. The data obtained from actigraphic recordings are used for diagnosing various disorders related to sleep such as obstructive sleep apnea (OSA), periodic limb movement disorder (PLMD), central nervous system depression (CNSD) etc.
Application Insights:
The drug manufacturers segment dominated the global market in terms of revenue in 2017. This is owing to factors such as high prevalence of sleep apnea and growing awareness about available treatment options among end-users. Furthermore, increasing R&D investments by major players are expected to boost product demand over the forecast period.
Hospitals and clinics are estimated to be the fastest-growing application segment during the study period due to rising prevalence of diseases, such as obstructive sleep apnea (OSA) and other associated conditions across various regions coupled with limited availability of advanced healthcare facilities at a domestic level. In addition, private institutes also offer diagnostic services but at a higher cost which may restrict overall growth on account of profitability issues for certain market players over the forecast period. However, government research institutes exhibit lucrative opportunities for growth due to increased funding from governments resulting in increased spending on medical devices & equipment thereby boosting product demand globally during future years.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high awareness levels pertaining to sleep disorders, and availability of effective treatment for sleep apnea are some factors attributing to its large share. Moreover, increasing prevalence of obesity is also contributing toward the growth of this regional market. According to a study published by National Center for Health Statistics (NCHS), in 2014 around 30% population aged 6 years and above was suffering from obesity at that time.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing target population base especially in India & China and other emerging economies such as Indonesia & Malaysia etc.
Growth Factors:
- Increasing prevalence of sleep apnea: The global prevalence of sleep apnea is estimated to be around 4-5%. However, the actual number of people suffering from the disorder could be much higher as a large number of cases go undiagnosed. This is primarily because sleep apnea often goes undetected due to its subtle symptoms. With increasing awareness about the disorder and improved diagnosis techniques, the market for sleep apnea diagnostics and therapeutics is expected to grow at a healthy rate in the coming years.
- Growing demand for home-based treatment options: A large majority of patients with sleep apnea prefer home-based treatment options over invasive procedures such as surgery. This has led to an increase in demand for devices such as CPAP machines that can be used at home for treatingsleep apnea. The market for home-based devices is expected to grow rapidly in the coming years, providing lucrative opportunities for players operating in this space.
- Rising incidence of obesity: Obesity is one of the leading risk factorsfor developingsleep apnea . As obesity rates continue to rise across the globe, so willthe incidenceofsleepapneain adults . This will create significant growth opportunitiesfor players operating in this space and help boost sales revenues significantly overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Sleep Apnea Diagnostics and Therapeutics Market Research Report
By Type
Polysomnography (PSG) Devices, Actigraphy Systems, Respiratory Polygraph, Pulse Oximeters, Others
By Application
Drug Manufacturers, Hospitals and Clinics, Private and Government Research Institutes, Academic Institutes
By Companies
Philips Respironics, ResMed, Becton, Dickinson and Company (CareFusion), Teleflex, Fisher and Paykel Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Sleep Apnea Diagnostics and Therapeutics Market Report Segments:
The global Sleep Apnea Diagnostics and Therapeutics market is segmented on the basis of:
Types
Polysomnography (PSG) Devices, Actigraphy Systems, Respiratory Polygraph, Pulse Oximeters, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Manufacturers, Hospitals and Clinics, Private and Government Research Institutes, Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips Respironics
- ResMed
- Becton
- Dickinson and Company (CareFusion)
- Teleflex
- Fisher and Paykel Healthcare
Highlights of The Sleep Apnea Diagnostics and Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polysomnography (PSG) Devices
- Actigraphy Systems
- Respiratory Polygraph
- Pulse Oximeters
- Others
- By Application:
- Drug Manufacturers
- Hospitals and Clinics
- Private and Government Research Institutes
- Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sleep Apnea Diagnostics and Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sleep apnea is a sleep disorder in which people stop breathing for brief periods of time during sleep. This can cause problems with daytime functioning, including increased risk for accidents and heart disease. There are many different types of sleep apnea, but the most common is obstructive sleep apnea (OSA), in which airway obstruction causes repeated episodes of shallow breathing during sleep. OSA often leads to excessive daytime fatigue and poor concentration. Sleep apnea treatments include lifestyle changes (such as weight loss) and medications (such as CPAP therapy).
Some of the major players in the sleep apnea diagnostics and therapeutics market are Philips Respironics, ResMed, Becton, Dickinson and Company (CareFusion), Teleflex, Fisher and Paykel Healthcare.
The sleep apnea diagnostics and therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sleep Apnea Diagnostics and Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sleep Apnea Diagnostics and Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sleep Apnea Diagnostics and Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sleep Apnea Diagnostics and Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sleep Apnea Diagnostics and Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Sleep Apnea Diagnostics and Therapeutics Market Size and Y-o-Y Growth
4.5.2 Sleep Apnea Diagnostics and Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Sleep Apnea Diagnostics and Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
5.2.1 Polysomnography (PSG) Devices
5.2.2 Actigraphy Systems
5.2.3 Respiratory Polygraph
5.2.4 Pulse Oximeters
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sleep Apnea Diagnostics and Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
6.2.1 Drug Manufacturers
6.2.2 Hospitals and Clinics
6.2.3 Private and Government Research Institutes
6.2.4 Academic Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sleep Apnea Diagnostics and Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sleep Apnea Diagnostics and Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
9.6.1 Polysomnography (PSG) Devices
9.6.2 Actigraphy Systems
9.6.3 Respiratory Polygraph
9.6.4 Pulse Oximeters
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
9.10.1 Drug Manufacturers
9.10.2 Hospitals and Clinics
9.10.3 Private and Government Research Institutes
9.10.4 Academic Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sleep Apnea Diagnostics and Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
10.6.1 Polysomnography (PSG) Devices
10.6.2 Actigraphy Systems
10.6.3 Respiratory Polygraph
10.6.4 Pulse Oximeters
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
10.10.1 Drug Manufacturers
10.10.2 Hospitals and Clinics
10.10.3 Private and Government Research Institutes
10.10.4 Academic Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sleep Apnea Diagnostics and Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
11.6.1 Polysomnography (PSG) Devices
11.6.2 Actigraphy Systems
11.6.3 Respiratory Polygraph
11.6.4 Pulse Oximeters
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
11.10.1 Drug Manufacturers
11.10.2 Hospitals and Clinics
11.10.3 Private and Government Research Institutes
11.10.4 Academic Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sleep Apnea Diagnostics and Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
12.6.1 Polysomnography (PSG) Devices
12.6.2 Actigraphy Systems
12.6.3 Respiratory Polygraph
12.6.4 Pulse Oximeters
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
12.10.1 Drug Manufacturers
12.10.2 Hospitals and Clinics
12.10.3 Private and Government Research Institutes
12.10.4 Academic Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sleep Apnea Diagnostics and Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Type
13.6.1 Polysomnography (PSG) Devices
13.6.2 Actigraphy Systems
13.6.3 Respiratory Polygraph
13.6.4 Pulse Oximeters
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sleep Apnea Diagnostics and Therapeutics Market Size Forecast by Applications
13.10.1 Drug Manufacturers
13.10.2 Hospitals and Clinics
13.10.3 Private and Government Research Institutes
13.10.4 Academic Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sleep Apnea Diagnostics and Therapeutics Market: Competitive Dashboard
14.2 Global Sleep Apnea Diagnostics and Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Philips Respironics
14.3.2 ResMed
14.3.3 Becton
14.3.4 Dickinson and Company (CareFusion)
14.3.5 Teleflex
14.3.6 Fisher and Paykel Healthcare
